Immortal time bias in observational studies of drug effects. Immortal time bias in observational studies of drug effects. Suissa S. Comment in Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):1036. PURPOSE: Recent ...
Immortal time bias in observational studies of drug effects in ... 2014年7月1日 - Immortal time bias in observational studies of drug effects in pregnancy. Matok I, Azoulay L, Yin H, Suissa S. BACKGROUND: The use of ...
Metformin and the risk of cancer: time-related biases in ... OBJECTIVE: Time-related biases in observational studies of drug effects have been ... Immortal time bias, time-window bias, and time-lag bias all tend to greatly ...
4.2.2.2.1. Immortal time bias - ENCePP Home Page Immortal time bias in observational studies of drug effects (Pharmacoepidemiol Drug Saf 2007;16:241-9) demonstrates how several observational studies used ...
4.2.2.2. Time-related bias - ENCePP Home Page Immortal time bias in observational studies of drug effects (Pharmacoepidemiol Drug Saf 2007;16:241-9) demonstrates how several observational studies used ...
Metformin and the Risk of Cancer: Time-related biases in ... OBJECTIVEdTime-related biases in observational studies of drug effects have ... found that 13 observational studies suffered from immortal time bias; 9 stud-.
Immortal time bias in observational studies of drug effects 2007年1月25日 - Immortal time bias in observational studies of drug effects y. Samy Suissa PhD1,2*. 1From the McGill Pharmacoepidemiology Research Unit, ...
Immortal time bias in observational studies of drug effects ... 2007年1月25日 - Recent observational studies suggest that various drugs are remarkably effective at reducing morbidity and mortality. These cohort studies ...
Immortal Time Bias in Pharmacoepidemiology 2007年12月3日 - In a previous paper, I identified 20 observational studies of the effects of commonly prescribed drugs that were subject to immortal time bias ...
Immortal time bias must be considered in observational ... studies. Immortal time bias must be considered in observational studies. Jiannong Liu ... References: 1) Suissa S. Pharmacoepid Drug Safety 2007; 16: 241–249.
